Thipphawong, J.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

A randomized, double-blind comparison of OROS®hydromorphone and controlled-release morphine for the control of chronic cancer pain

Magdi Hanna, John Thipphawong, the 118 study group

Journal:

BMC Palliative Care

Year:

2008

Language:

english

File:

PDF, 1.93 MB

english, 2008

2

Conversion from Standard Opioid Therapy to Once-daily Oral Extended-release Hydromorphone in Patients with Chronic Cancer Pain

Wallace, M., Rauck, R., Moulin, D., Thipphawong, J., Khanna, S., Tudor, I.

Journal:

Journal of International Medical Research

Year:

2008

Language:

english

File:

PDF, 211 KB

english, 2008

3

661 LONG-TERM ASSESSMENT OF THE CLINICAL EFFICACY AND SAFETY OF ONCE-DAILY OROS® HYDROMORPHONE IN PATIENTS WITH SEVERE CHRONIC PAIN

M. Ates, U. Richarz, S. Waechter, J. Thipphawong, J.C. Tudor

Journal:

European Journal of Pain

Year:

2006

Language:

english

File:

PDF, 53 KB

english, 2006

4

694 QUALITY-OF-LIFE ASSESSMENT OF ONCE-DAILY OROS® HYDROMORPHONE VERSUS PLACEBO IN PATIENTS WITH MODERATE TO SEVERE CHRONIC OSTEOARTHRITIS PAIN

U. Richarz, R.R. Eckardt, S. Khanna, J. Thipphawong, R. Skowronski, J.C. Tudor

Journal:

European Journal of Pain

Year:

2006

Language:

english

File:

PDF, 54 KB

english, 2006

5

711 DOUBLE-BLIND, PLACEBO-CONTROLLED, REPEAT-DOSE ASSESSMENT OF ONCE-DAILY OROS® HYDROMORPHONE IN PATIENTS WITH MODERATE TO SEVERE CHRONIC OSTEOARTHRITIS PAIN

S. Waechter, R.R. Eckardt, S. Khanna, J. Thipphawong, R. Skowronski, J.C. Tudor

Journal:

European Journal of Pain

Year:

2006

Language:

english

File:

PDF, 58 KB

english, 2006

6

An open-label, 1-year extension study of the long-term safety and efficacy of once-daily OROS®hydromorphone in patients with chronic cancer pain

Magdi Hanna, Alberto Tuca, John Thipphawong

Journal:

BMC Palliative Care

Year:

2009

Language:

english

File:

PDF, 1.07 MB

english, 2009

7

Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone

Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta

Journal:

BMC Clinical Pharmacology

Year:

2007

Language:

english

File:

PDF, 1.14 MB

english, 2007

8

Pharmacokinetic profile of a 24-hour controlled-release OROS®formulation of hydromorphone in the presence and absence of food

Gayatri Sathyan, Emily Xu, John Thipphawong, Suneel K Gupta

Journal:

BMC Clinical Pharmacology

Year:

2007

Language:

english

File:

PDF, 1.01 MB

english, 2007

9

Open-Label Study on the Long-Term Efficacy, Safety, and Impact on Quality of Life of OROS Hydromorphone ER in Patients with Chronic Low Back Pain

Mark Wallace, John Thipphawong

Journal:

Year:

2010

Language:

english

File:

PDF, 518 KB

english, 2010

10

Once-daily OROS® hydromorphone for the management of chronic nonmalignant pain: a dose-conversion and titration study

M. Wallace, R. L. Rauck, D. Moulin, J. Thipphawong, S. Khanna, I. C. Tudor

Journal:

International Journal of Clinical Practice

Year:

2007

Language:

english

File:

PDF, 610 KB

english, 2007

11

Augmentation of Human Influenza A Virus-Specific Cytotoxic T Lymphocyte Memory by Influenza Vaccine and Adjuvanted Carriers (ISCOMS)

Francis A. Ennis, John Cruz, Julie Jameson, Michel Klein, David Burt, John Thipphawong

Journal:

Year:

1999

Language:

english

File:

PDF, 119 KB

english, 1999

12

Inhaled cytokines and cytokine antagonists

John Thipphawong

Journal:

Advanced Drug Delivery Reviews

Year:

2006

Language:

english

File:

PDF, 249 KB

english, 2006

13

Clinical Trial Results with OROS® Hydromorphone

Mark S. Wallace, John Thipphawong

Journal:

Journal of Pain and Symptom Management

Year:

2007

Language:

english

File:

PDF, 290 KB

english, 2007

14

Results of a Double-blind, Placebo-controlled, Fixed-dose Assessment of Once-daily OROS® Hydromorphone ER in Patients with Moderate to Severe Pain Associated with Chronic Osteoarthritis

Richard Rauck, Ronald Rapoport, John Thipphawong

Journal:

Year:

2012

Language:

english

File:

PDF, 488 KB

english, 2012

15

Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence of alcohol

Sathyan, G., Sivakumar, K., Thipphawong, J.

Journal:

Current Medical Research and Opinion

Year:

2008

Language:

english

File:

PDF, 419 KB

english, 2008

16

Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children

David W. Scheifele, William Meekison, Roland Guasparini, Ann Roberts, Luis Barreto, John Thipphawong, Sharon Wiltsey

Journal:

Year:

1995

Language:

english

File:

PDF, 695 KB

english, 1995

17

Efficacy and tolerability of once-daily OROS® hydromorphone and twice-daily extended-release oxycodone in patients with chronic, moderate to severe osteoarthritis pain: Results of a 6-week, randomized, open-label, noninferiority analysis

Martin Hale, Iulia Cristina Tudor, Sarita Khanna, John Thipphawong

Journal:

Clinical Therapeutics

Year:

2007

Language:

english

File:

PDF, 1.10 MB

english, 2007

18

Pharmacokinetic stability of OROS® hydromorphone ER: a population pharmacokinetic analysis in patients with chronic osteoarthritis pain

J. Thipphawong, K. Devarakonda, G. Sathyan

Journal:

The Journal of Pain

Year:

2012

Language:

english

File:

PDF, 31 KB

english, 2012

19

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age

Elaine Mills, Ronald Gold, John Thipphawong, Luis Barreto, Roland Guasparini, William Meekison, Les Cunning, Margaret Russell, Dana Harrison, Melody Boyd, Fang Xie

Journal:

Year:

1998

Language:

english

File:

PDF, 1.31 MB

english, 1998

20

Assessing the abuse potential of an oral osmotic-controlled extended release (OROS) hydromorphone compared to immediate release hydromorphone

M. Shram, M. Romach, E. Sellers, J. Thipphawong

Journal:

The Journal of Pain

Year:

2009

Language:

english

File:

PDF, 37 KB

english, 2009

21

Open-label extension study on the long-term efficacy, safety, and impact on quality of life of OROS® hydromorphone extended release in patients with chronic low back pain

M. Wallace, J. Thipphawong

Journal:

The Journal of Pain

Year:

2009

Language:

english

File:

PDF, 35 KB

english, 2009

22

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in treatment of patients with moderate-to-severe osteoarthritis pain

P. Sanga, N. Katz, E. Polverejan, S. Wang, K. Kelly, C. Oh, J. Thipphawong

Journal:

The Journal of Pain

Year:

2011

Language:

english

File:

PDF, 36 KB

english, 2011

23

Impact of pain relief with fulranumab in the treatment of patients with moderate to severe osteoarthritis pain

S. Vallow, P. Sanga, E. Polverejan, S. Wang, K. Kelly, J. Thipphawong

Journal:

The Journal of Pain

Year:

2011

Language:

english

File:

PDF, 35 KB

english, 2011

24

Efficacy, safety, and tolerability of fulranumab in treatment of patients with moderate-to-severe, chronic low back pain

P. Sanga, K. Karcher, S. Wang, K. Kelly, C. Oh, J. Thipphawong

Journal:

The Journal of Pain

Year:

2011

Language:

english

File:

PDF, 36 KB

english, 2011

25

(810): Patient and investigator evaluation of pain relief with OROS hydromorphone in the treatment of chronic osteoarthritis pain

S. Roth, A. Hamdy, S. Khanna, N. Abrouk, J. Thipphawong

Journal:

The Journal of Pain

Year:

2006

Language:

english

File:

PDF, 47 KB

english, 2006

26

(796): Pharmacokinetics of OROS hydromorphone are dose proportional and minimally affected by food

G. Sathyan, E. Xu, J. Thipphawong, S. Gupta

Journal:

The Journal of Pain

Year:

2006

Language:

english

File:

PDF, 52 KB

english, 2006

27

(806): Long-term safety and efficacy of OROS hydromorphone in patients with chronic low back pain

M. Wallace, R. Skowronski, S. Khanna, N. Abrouk, J. Thipphawong

Journal:

The Journal of Pain

Year:

2006

Language:

english

File:

PDF, 44 KB

english, 2006

28

(809): Clinical and quality of life benefits of once-daily OROS hydromorphone on pain relief in patients with chronic low back pain

M. Wallace, R. Skowronski, S. Khanna, N. Abrouk, J. Thipphawong

Journal:

The Journal of Pain

Year:

2006

Language:

english

File:

PDF, 47 KB

english, 2006

29

Poster 269: Open-label Extension Study on the Long-Term Safety, Impact on Quality of Life and Clinical Utility of OROS® Hydromorphone Extended Release in Patients with Chronic Low Back Pain

Mark S. Wallace, John Thipphawong

Journal:

Year:

2009

Language:

english

File:

PDF, 58 KB

english, 2009

30

Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain

Sanga, Panna, Katz, Nathaniel, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Haeussler, Juergen, Thipphawong, John

Journal:

Year:

2013

Language:

english

File:

PDF, 988 KB

english, 2013

31

Adjudication process for joint events of interest in fulranumab clinical trial program

Moskowitz, R., Brandt, K., Lequesne, M., Mont, M.A., Kneeland, B., Sanga, P., Mayorga, A., Kelly, K.M., Upmalis, D., Thipphawong, J., Pierce, P.

Journal:

Osteoarthritis and Cartilage

Year:

2013

Language:

english

File:

PDF, 56 KB

english, 2013

32

Erratum to: “Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain” [PAIN® 2013;154(10):1910–19]

Sanga, Panna, Katz, Nathaniel, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Haeussler, Juergen, Thipphawong, John

Journal:

Year:

2014

File:

PDF, 96 KB

2014

33

Peripheral nerve safety measures in a multicenter, double-blind, randomized, placebo-controlled, dose-ranging study of fulranumab in patients with painful diabetic neuropathy

Polydefkis, M., Wang, H., Romano, G., Frustaci, M.E., Cornblath, D., Thipphawong, J., Kelly, K.M., Arezzo, J.

Journal:

Journal of the Neurological Sciences

Year:

2013

Language:

english

File:

PDF, 66 KB

english, 2013

34

Analgesic efficacy of fulranumab in patients with painful diabetic peripheral neuropathy in a randomized, placebo-controlled, double-blind study

Wang, H., Romano, G., Frustaci, M.E., Sanga, P., Ness, S., Russell, L.J., Fedgchin, M., Kelly, K.M., Thipphawong, J.

Journal:

Journal of the Neurological Sciences

Year:

2013

Language:

english

File:

PDF, 79 KB

english, 2013

35

Double-blind, randomized study to evaluate efficacy, and safety of fulranumab in patients with moderate to severe, chronic knee pain from osteoarthritis: interim analysis results

Mayorga, A., Wang, S., Wang, S., Kelly, K., Thipphawong, J.

Journal:

The Journal of Pain

Year:

2013

Language:

english

File:

PDF, 93 KB

english, 2013

36

Pulmonary Insulin Administration Using the AERx ® Insulin Diabetes System

Thipphawong, John, Otulana, Babatunde, Clauson, Per, Okikawa, Jerry, Farr, Stephen J.

Journal:

Diabetes Technology & Therapeutics

Year:

2002

Language:

english

File:

PDF, 448 KB

english, 2002

37

Efficacy of the Sustained-Release Hydromorphone in Neuropathic Pain Management: Pooled Analysis of Three Open-Label Studies

Moulin, Dwight E., Richarz, Ute, Wallace, Mark, Jacobs, Adam, Thipphawong, John

Journal:

Journal of Pain and Palliative Care Pharmacotherapy

Year:

2010

Language:

english

File:

PDF, 524 KB

english, 2010

38

Bolus Inhalation of rhDNase with the AERx System in Subjects with Cystic Fibrosis

Geller, David, Thipphawong, John, Otulana, Babatunde, Caplan, Daniel, Ericson, Dawn, Milgram, Laura, Okikawa, Jerry, Quan, Joanne, Bowman, C. Michael

Journal:

Journal of Aerosol Medicine

Year:

2003

Language:

english

File:

PDF, 164 KB

english, 2003

39

Efficacy and safety evaluation of once-daily OROS hydromorphone in patients with chronic low back pain: a pilot open-label study (DO‑127)

Wallace, Mark, Skowronski, Roman, Khanna, Sarita, Cristina Tudor, Iulia, Thipphawong, John

Journal:

Current Medical Research and Opinion

Year:

2007

Language:

english

File:

PDF, 403 KB

english, 2007

40

Fulranumab for treatment of diabetic peripheral neuropathic pain: A randomized controlled trial

Wang, H., Romano, G., Frustaci, M. E., Bohidar, N., Ma, H., Sanga, P., Ness, S., Russell, L. J., Fedgchin, M., Kelly, K. M., Thipphawong, J.

Journal:

Year:

2014

Language:

english

File:

PDF, 558 KB

english, 2014

41

Poliovirus Vaccination Schedules and Reversion to Virulence

Murdin, A. D., Thipphawong, J.

Journal:

The Journal of Infectious Diseases

Year:

1992

Language:

english

File:

PDF, 201 KB

english, 1992

42

The pharmacokinetics of a long-acting OROS hydromorphone formulation

Turgeon, J, Gröning, R, Sathyan, G, Thipphawong, J, Richarz, U

Journal:

Expert Opinion on Drug Delivery

Year:

2010

Language:

english

File:

PDF, 543 KB

english, 2010

43

Pharmacokinetics and Acute Safety of Inhaled Testosterone in Postmenopausal Women

Davison, Sonia, Thipphawong, John, Blanchard, Jim, Liu, Kui, Morishige, Richard, Gonda, Igor, Okikawa, Jerry, Adams, Jennifer, Evans, Allan, Otulana, Babatunde, Davis, Susan

Journal:

Journal of Clinical Pharmacology

Year:

2005

Language:

english

File:

PDF, 134 KB

english, 2005

44

Efficacy, Safety, and Tolerability of Fulranumab as an Adjunctive Therapy in Patients With Inadequately Controlled, Moderate-to-Severe Chronic Low Back Pain: A Randomized, Double-blind, Placebo-controlled, Dose-Ranging, Dose-Loading Phase II Study

Sanga, Panna, Polverejan, Elena, Wang, Steven, Kelly, Kathleen M., Thipphawong, John

Journal:

Clinical Therapeutics

Year:

2016

Language:

english

File:

PDF, 470 KB

english, 2016

45

Measles vaccination of infants in a well-vaccinated population

CARSON, MARY M., SPADY, DONALD W., ALBRECHT, PAUL, BEELER, JUDY A., THIPPHAWONG, JOHN, BARRETO, LUIS, GRIMSRUD, KAREN M., PABST, HENRY F.

Journal:

Pediatric Infectious Disease Journal

Year:

1995

File:

PDF, 561 KB

1995

46

Analgesic Efficacy of Inhaled Morphine in Patients after Bunionectomy Surgery

Thipphawong, John B., Babul, Najib, Morishige, Richard J., Findlay, Hugh K., Reber, Keith R., Millward, Gary J., Otulana, Babatunde A.

Journal:

Year:

2003

Language:

english

File:

PDF, 512 KB

english, 2003

47

(382) Efficacy, safety, and tolerability of Fulranumab as adjunctive therapy for cancer-related pain: a randomized, double-blind, placebo-controlled, multicenter study

Slatkin, N., Zaki, N., Sanga, P., Wang, S., Louie, J., Kelly, K., Thipphawong, J.

Journal:

The Journal of Pain

Year:

2016

Language:

english

File:

PDF, 50 KB

english, 2016

48

Evaluation of the Abuse Potential of Extended Release Hydromorphone Versus Immediate Release Hydromorphone

Shram, Megan J., Sathyan, Gayatri, Khanna, Sarita, Tudor, Iulia Cristina, Nath, Rajneesh, Thipphawong, John, Sellers, Edward M.

Journal:

Journal of Clinical Psychopharmacology

Year:

2010

Language:

english

File:

PDF, 979 KB

english, 2010

49

Fulranumab in Patients with Pain Associated with Postherpetic Neuralgia and Postraumatic Neuropathy

Wang, Hao, Romano, Gary, Fedgchin, Margaret, Russell, Lucille, Sanga, Panna, Kelly, Kathleen M., Frustaci, Mary Ellen, Thipphawong, John

Journal:

Clinical Journal of Pain

Year:

2016

Language:

english

File:

PDF, 2.22 MB

english, 2016

50

Poliovirus Vaccination Schedules and Reversion to Virulence [with Reply]

Andrew D. Murdin, John Thipphawong and Pearay L. Ogra

Journal:

The Journal of Infectious Diseases

Year:

1992

Language:

english

File:

PDF, 496 KB

english, 1992

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски